Clinical trial
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical…
NCT00004261 · University Health Network, Toronto, Other · Terminated
Key facts
| NCT number | NCT00004261 |
|---|---|
| Title | EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma |
| Official title | A Phase I Trial of the Hypoxia Detection Agent EF5 (NSC 684681) in Patients With Cervix and Breast and Prostate Carcinomas, and High Grade Soft Tissue Sarcomas |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Cervical Cancer, Head and Neck Cancer, Prostate Cancer, Sarcoma |
| Intervention type | Drug, Other, Procedure |
| Interventions | EF5, flow cytometry, fluorescent antibody technique, immunohistochemistry staining method, biopsy |
| Start date | Dec 1, 1999 |
| Primary completion | Jun 1, 2002 |
| First posted | Dec 11, 2003 |
| Last update posted | Feb 22, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: